Li Zhu

Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma

Jun Liu, Yang Yang, Zhichao Liu et al. · Journal for ImmunoTherapy of Cancer · 2022 · 278 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Acquisition of epithelial–mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells

Qingling Yang, Jingwen Huang, Qiong Wu et al. · British Journal of Cancer · 2014 · 130 citations · Full text

Medicine, Oncology, Pharmacology +17

Abstract CT116: BMS-986205, an optimized indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, is well tolerated with potent pharmacodynamic (PD) activity, alone and in combination with nivolumab (nivo) in advanced cancers in a phase 1/2a trial

Lillian L. Siu, Karen A. Gelmon, Quincy S. Chu et al. · Cancer Research · 2017 · 86 citations

Medicine, Oncology, Pharmacology +17

Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer

Biao Wang, Zhen Tang, Huiyuan Gong et al. · Bioscience Reports · 2017 · 78 citations · Full text

Medicine, Molecular Biology, Oncology +17

Royal Free Hospital-Nutritional Prioritizing Tool improves the prediction of malnutrition risk outcomes in liver cirrhosis patients compared with Nutritional Risk Screening 2002

Yuchao Wu, Yage Zhu, Yali Feng et al. · British Journal Of Nutrition · 2020 · 78 citations · Full text

Agriculture, Nutrition, Nutritional Sciences +17